Correction: Estrogen signalling and the metabolic syndrome: Targeting the hepatic estrogen receptor alpha action(PLoS ONE (2013) 8:2 (e57458) DOI: 10.1371/journal.pone.0057458);Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Matic, Marko ^a   Bryzgalova, Galyna ^b   Gao, Hui ^a   Antonson, Per ^a   Humire, Patricia ^a   Omoto, Yoko ^a   Portwood, Neil ^b   Pramfalk, Camilla ^a   Efendic, Suad ^b   Berggren, Per Olof ^b   Gustafsson, Jan Åke ^a,c   Dahlman Wright, Karin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GLUCOSE; INSULIN; RNA; TRIACYLGLYCEROL;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID DIET; LIVER; MALE; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

EID: 84874396118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0217526     Document Type: Erratum

References (52)

1. Kendall DM, Harmel AP, (2002) The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care 8: S635-653; quiz S654-637.
2. Borch-Johnsen K, (2007) The metabolic syndrome in a global perspective. The public health impact--secondary publication. Dan Med Bull 54: 157-159.
3. Bruce KD, Hanson MA, (2010) The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 140: 648-652.
4. Lundholm L, Bryzgalova G, Gao H, Portwood N, Falt S, et al. (2008) The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms. J Endocrinol 199: 275-286.
5. Grundy SM, (2008) Metabolic syndrome pandemic. Arteriosclerosis, thrombosis, and vascular biology 28: 629-636.
6. Eshtiaghi R, Esteghamati A, Nakhjavani M, (2010) Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 65: 262-266.
7. Munoz J, Derstine A, Gower BA, (2002) Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obesity research 10: 424-431.
8. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, et al. (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. The New England journal of medicine 331: 1056-1061.
9. Jones ME, Boon WC, McInnes K, Maffei L, Carani C, et al. (2007) Recognizing rare disorders: aromatase deficiency. Nature clinical practice Endocrinology & metabolism 3: 414-421.
10. Jones ME, Boon WC, Proietto J, Simpson ER, (2006) Of mice and men: the evolving phenotype of aromatase deficiency. Trends in endocrinology and metabolism: TEM 17: 55-64.
11. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS, (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97: 12729-12734.
12. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, et al. (2006) Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49: 588-597.
13. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, et al. (2003) Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. The Journal of endocrinology 176: 237-246.
14. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, et al. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proceedings of the National Academy of Sciences of the United States of America 97: 12735-12740.
15. Bailey CJ, Ahmed-Sorour H, (1980) Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. Diabetologia 19: 475-481.
16. Ahmed-Sorour H, Bailey CJ, (1980) Role of ovarian hormones in the long-term control of glucose homeostasis. Interaction with insulin, glucagon and epinephrine. Horm Res 13: 396-403.
17. Lindberg MK, Weihua Z, Andersson N, Moverare S, Gao H, et al. (2002) Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. The Journal of endocrinology 174: 167-178.
18. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, et al. (2005) Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. The Journal of biological chemistry 280: 35983-35991.
19. Gao H, Bryzgalova G, Hedman E, Khan A, Efendic S, et al. (2006) Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol 20: 1287-1299.
20. Bryzgalova G, Lundholm L, Portwood N, Gustafsson JA, Khan A, et al. (2008) Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab 295: E904-912.
21. Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, et al. (2000) Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 74: 279-285.
22. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, et al. (2006) International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacological reviews 58: 773-781.
23. Foryst-Ludwig A, Clemenz M, Hohmann S, Hartge M, Sprang C, et al. (2008) Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet 4: e1000108.
24. Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, et al. (2007) Silencing of estrogen receptor in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proceedings of the National Academy of Sciences 104: 2501-2506.
25. Ribas V, Drew BG, Le JA, Soleymani T, Daraei P, et al. (2011) Myeloid-specific estrogen receptor {alpha} deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proceedings of the National Academy of Sciences of the United States of America.
26. Xu Y, Nedungadi TP, Zhu L, Sobhani N, Irani BG, et al. (2011) Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metabolism 14: 453-465.
27. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER, (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
28. Martensson UE, Salehi SA, Windahl S, Gomez MF, Sward K, et al. (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150: 687-698.
29. Aronoff SL, Berkowitz K, Shreiner B, (2004) Glucose Metabolism and Regulation: Beyond Insulin and Glucagon. Diabetes Spectrum 17: 183-190.
30. Ahlborg G, Wahren J, Felig P, (1986) Splanchnic and peripheral glucose and lactate metabolism during and after prolonged arm exercise. The Journal of clinical investigation 77: 690-699.
31. Gerich JE, Meyer C, Woerle HJ, Stumvoll M, (2001) Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24: 382-391.
32. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature genetics 29: 365-371.
33. Knebel B, Haas J, Hartwig S, Jacob S, Kollmer C, et al. (2012) Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass. PLoS One 7: e31812.
34. Aragno M, Tomasinelli CE, Vercellinatto I, Catalano MG, Collino M, et al. (2009) SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free radical biology & medicine 47: 1067-1074.
35. Ferre P, Foufelle F, (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes, obesity & metabolism 12 (Suppl 2):: 83-92.
36. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA, (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the United States of America 93: 5925-5930.
37. Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, et al. (2008) Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 47: 1924-1935.
38. Della Torre S, Rando G, Meda C, Stell A, Chambon P, et al. (2011) Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell metabolism 13: 205-214.
39. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, et al. (2010) Kupffer cell activation is a causal factor for hepatic insulin resistance. American journal of physiology Gastrointestinal and liver physiology 298: G107-116.
40. Postic C, Magnuson MA, (2000) DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26: 149-150.
41. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, et al. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870.
42. Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, et al. (2010) Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. American journal of physiology Endocrinology and metabolism 298: E304-319.
43. Eckel RH, Grundy SM, Zimmet PZ, (2005) The metabolic syndrome. Lancet 365: 1415-1428.
44. Antonson P, Omoto Y, Humire P, Gustafsson JA, (2012) Generation of ERalpha-floxed and knockout mice using the Cre/LoxP system. Biochemical and Biophysical Research Communications 424: 710-716.
45. Hsu SM, Raine L, Fanger H, (1981) A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. American journal of clinical pathology 75: 734-738.
46. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome biology 5: R80.
47. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research 30: 207-210.
48. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative CT method. Nature Protocols 3: 1101-1108.
49. Welinder C, Ekblad L, (2011) Coomassie staining as loading control in Western blot analysis. Journal of proteome research 10: 1416-1419.
50. Abramoff MD, Magalhaes PJ, Ram SJ, (2004) Image Processing with ImageJ. Biophotonics International 11: 36-42.
51. Bligh EG, Dyer WJ, (1959) A rapid method of total lipid extraction and purification. Canadian journal of biochemistry and physiology 37: 911-917.
52. Ohshiro T, Matsuda D, Sakai K, Degirolamo C, Yagyu H, et al. (2011) Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia. Arteriosclerosis, thrombosis, and vascular biology 31: 1108-1115.